HUMA logo

Humacyte, Inc. (HUMA)

Profile

Full Name

Humacyte, Inc.

Ticker

NASDAQ: HUMA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 1, 2020

Indexes

Not included

Website

https://humacyte.com

Employees

218

Key Details

Price

$0.96(-4.85%)

Market Cap

$179.97M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$1.26(-17.18% YoY)

PE Ratio

-

Next earnings date

Mar 27, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.96
    HUMA price is $0.96

    30-Day Relative Volume

    2.19
    HUMA 30-day relative volume is 2.19

    Price Performance

    Price Most Recent Change

    -4.85%
    HUMA price was down -4.85% on Dec 31, 2025

    Price YTD Change

    -80.97%
    HUMA price is down -80.97% since January 1st

    Price 1-Year Change

    -80.97%
    HUMA price is down -80.97% year-on-year

    Price 3-Year Change

    -54.45%
    HUMA price is down -54.45% over the past 3 years

    Price Range

    Price All-Time High

    $17.45
    HUMA price is currently -94.49% below its historical high of $17.45

    Price 3-Year Low

    $0.91
    HUMA price is currently +5.60% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $179.97M
    HUMA market cap is $179.97 million

    Market Cap 3-Year Change

    -17.38%
    HUMA market cap is down -17.38% over the past 3 years

    Market Cap All-Time High

    $1.75B
    HUMA market cap is currently -89.72% below its historical high of $1.75 billion

    Market Cap Sector Percentile

    47.88%
    HUMA market cap is higher than 47.88% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +45.55%
    HUMA shares outstanding is up +45.55% year-on-year

    Shares Outstanding 3-Year Change

    +81.61%
    HUMA shares outstanding is up +81.61% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    2.27
    HUMA beta is 2.27

    200-day SMA

    $1.81
    HUMA price is currently -46.89% below its 200-day simple moving average

    50-day SMA

    $1.31
    HUMA price is currently -26.54% below its 50-day simple moving average

    14-Day RSI

    30.61
    HUMA 14-day relative strength index is 30.61

    Volume

    2.19
    HUMA 30-day relative volume is 2.19

    ATR

    $0.09
    HUMA average true range is $0.09

    10-day Historical Volatility

    58.88%
    HUMA 10-day historical volatility is 58.88%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    HUMA annual revenue is $0.00

    Revenue Analysts Estimate

    $2.84M
    HUMA annual revenue is currently -100.00% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    0%
    HUMA annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.46%
    HUMA annual revenue is higher than 28.46% of companies in Healthcare sector

    EPS

    EPS

    -$1.26
    HUMA annual earnings per share is -$1.26

    EPS Analysts Estimate

    -$0.38
    HUMA annual earnings per share is currently -226.85% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -17.18%
    HUMA annual earnings per share is down -17.18% year-on-year

    EPS Sector Percentile

    50.43%
    HUMA annual earnings per share is higher than 50.43% of companies in Healthcare sector

    Profit

    Gross Profit

    -$7.19M
    HUMA annual gross profit is -$7.19 million

    Gross Margin

    -
    HUMA annual gross profit margin value is unknown

    Operating Profit

    -$114.40M
    HUMA annual operating income is -$114.40 million

    Operating Margin

    -
    HUMA annual operating profit margin value is unknown

    Net Income

    -$148.70M
    HUMA annual net profit is -$148.70 million

    Net Margin

    -
    HUMA annual net profit margin value is unknown

    Expenses

    Total Expenses

    $114.40M
    HUMA annual total expenses is $114.40 million

    Operating Expenses

    $114.40M
    HUMA annual total operating expenses is $114.40 million

    Cost Of Goods Sold

    $7.19M
    HUMA annual cost of goods sold is $7.19 million

    Selling, General & Administrative Expenses

    $25.80M
    HUMA annual SG&A is $25.80 million

    Depreciation & Amortization

    $7.19M
    HUMA annual D&A is $7.19 million

    Interest Expense

    $9.28M
    HUMA annual interest expense is $9.28 million

    Income Tax

    $0.00
    HUMA annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$139.42M
    HUMA annual earnings before interest & taxes is -$139.42 million

    EBITDA

    -$132.23M
    HUMA annual EBITDA is -$132.23 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $137.87M
    HUMA annual total assets is $137.87 million

    Non Current Assets

    $90.01M
    HUMA annual long term assets is $90.01 million

    Current Assets

    $47.86M
    HUMA annual total current assets is $47.86 million

    Cash and Cash Equivalents

    $44.94M
    HUMA annual cash & cash equivalents is $44.94 million

    Accounts Receivable

    -
    HUMA annual accounts receivable value is unknown

    Inventory

    $0.00
    HUMA annual inventory is $0.00

    Liabilities

    Total Liabilities

    $190.54M
    HUMA annual total liabilities is $190.54 million

    Long Term Liabilities

    $170.59M
    HUMA annual total long term liabilities is $170.59 million

    Current Liabilities

    $19.95M
    HUMA annual current liabilities is $19.95 million

    Accounts Payable

    $4.49M
    HUMA annual accounts payable is $4.49 million

    Debt

    Total Debt

    $80.49M
    HUMA annual total debt is $80.49 million

    Total Debt 1-Year Change

    +38.52%
    HUMA annual total debt is up +38.52% year-on-year

    Long Term Debt

    $13.62M
    HUMA annual long term debt is $13.62 million

    Short Term Debt

    $2.92M
    HUMA annual short term debt is $2.92 million

    Equity & Capital

    Shareholders Equity

    -$52.67M
    HUMA annual stockholders equity is -$52.67 million

    Book Value

    -$52.67M
    HUMA annual book value is -$52.67 million

    Retained Earnings

    -$686.01M
    HUMA annual retained earnings is -$686.01 million

    Working Capital

    $27.91M
    HUMA annual working capital is $27.91 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$98.12M
    HUMA annual cash from operations is -$98.12 million

    Cash From Operations 1-Year Change

    -33.85%
    HUMA annual cash from operations is down -33.85% year-on-year

    Cash From Investing

    -$1.57M
    HUMA annual cash from investing is -$1.57 million

    Cash From Investing 1-Year Change

    -808.67%
    HUMA annual cash from investing is down -808.67% year-on-year

    Cash From Financing

    $114.18M
    HUMA annual cash from financing is $114.18 million

    Cash From Financing 1-Year Change

    +2433.46%
    HUMA annual cash from financing is up +2433.46% year-on-year

    CAPEX

    CAPEX

    $1.57M
    HUMA annual capital expenditures is $1.57 million

    CAPEX 1-Year Change

    -31.05%
    HUMA annual capital expenditures is down -31.05% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$99.69M
    HUMA annual free cash flow is -$99.69 million

    Free Cash Flow 1-Year Change

    -31.9%
    HUMA annual free cash flow is down -31.9% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    HUMA annual gross profit margin value is unknown

    Operating Margin

    -
    HUMA annual operating profit margin value is unknown

    Net Margin

    -
    HUMA annual net profit margin value is unknown

    ROA & ROE

    ROA

    -111.77%
    HUMA annual return on assets is -111.77%

    ROE

    282.33%
    HUMA annual return on equity is 282.33%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    HUMA price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    HUMA price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    -37.88
    HUMA price to book ratio is -37.88

    PB Ratio Sector Percentile

    1.53%
    HUMA price to book ratio is higher than 1.53% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    114.56
    HUMA price to sales ratio is 114.56

    PS Ratio Sector Percentile

    91.6%
    HUMA price to sales ratio is higher than 91.6% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $210.91M
    HUMA enterprise value is $210.91 million

    Enterprise Value Sector Percentile

    53.09%
    HUMA enterprise value is higher than 53.09% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -2.15
    HUMA EV/EBITDA is -2.15

    EV/EBITDA Sector Percentile

    37.12%
    HUMA EV/EBITDA is higher than 37.12% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    2.40
    HUMA annual current ratio is 2.40

    Quick Ratio

    2.40
    HUMA annual quick ratio is 2.40

    Leverage

    Debt To Equity

    -1.53
    HUMA annual debt to equity ratio is -1.53

    Interest Coverage Ratio

    -15.03
    HUMA annual interest coverage ratio is -15.03

    Risk & Stability

    F-Score

    -
    HUMA piotroski f-score value is unknown

    Altman Z-Score

    -9.49
    HUMA altman z-score is -9.49

    Analyst ratings

    Recent major analysts updates

    Nov 21, 25 BTIG
    Buy
    Nov 20, 25 D. Boral Capital
    Buy
    Nov 13, 25 D. Boral Capital
    Buy
    Nov 13, 25 Benchmark
    Buy
    Nov 12, 25 D. Boral Capital
    Buy
    Nov 10, 25 D. Boral Capital
    Buy
    Oct 13, 25 BTIG
    Buy
    Oct 6, 25 D. Boral Capital
    Buy
    Sep 30, 25 D. Boral Capital
    Buy
    Sep 18, 25 D. Boral Capital
    Buy

    Institutional Ownership

    Screeners with HUMA included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Humacyte, Inc.?
    • Does Humacyte, Inc. pay dividends?
    • What sector is Humacyte, Inc. in?
    • What industry is Humacyte, Inc. in?
    • What country is Humacyte, Inc. based in?
    • When did Humacyte, Inc. go public?
    • Is Humacyte, Inc. in the S&P 500?
    • Is Humacyte, Inc. in the NASDAQ 100?
    • Is Humacyte, Inc. in the Dow Jones?
    • When was Humacyte, Inc.'s last earnings report?
    • When does Humacyte, Inc. report earnings?

    What is the ticker symbol for Humacyte, Inc.?

    The ticker symbol for Humacyte, Inc. is NASDAQ:HUMA

    Does Humacyte, Inc. pay dividends?

    No, Humacyte, Inc. does not pay dividends

    What sector is Humacyte, Inc. in?

    Humacyte, Inc. is in the Healthcare sector

    What industry is Humacyte, Inc. in?

    Humacyte, Inc. is in the Biotechnology industry

    What country is Humacyte, Inc. based in?

    Humacyte, Inc. is headquartered in United States

    When did Humacyte, Inc. go public?

    Humacyte, Inc.'s initial public offering (IPO) was on December 1, 2020

    Is Humacyte, Inc. in the S&P 500?

    No, Humacyte, Inc. is not included in the S&P 500 index

    Is Humacyte, Inc. in the NASDAQ 100?

    No, Humacyte, Inc. is not included in the NASDAQ 100 index

    Is Humacyte, Inc. in the Dow Jones?

    No, Humacyte, Inc. is not included in the Dow Jones index

    When was Humacyte, Inc.'s last earnings report?

    Humacyte, Inc.'s most recent earnings report was on November 12, 2025

    When does Humacyte, Inc. report earnings?

    The next expected earnings date for Humacyte, Inc. is March 27, 2026
    On this page